home.social

#merck — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #merck, aggregated by home.social.

  1. Blue chip companies including #Merck, #Citi and #HomeDepot will expand use of #Google #Gemini Enterprise #AI agents on a revamped platform, but how far its appeal will extend beyond the #GoogleCloud user base remains to be seen.

    My writeup features comments from interviews and sessions at #GoogleCloudNext:

    techtarget.com/searchitoperati

  2. Global drug makers face pricing pressure as China targets affordable healthcare

    Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #astrazeneca #Beijing #China #donaldtrump #EliLilly #Gardasil #Health #keytruda #Merck #Mounjaro #Roche #Sanofi #Washington
    newsbeep.com/us/571163/

  3. Global drug makers face pricing pressure as China targets affordable healthcare

    Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #astrazeneca #Beijing #China #donaldtrump #EliLilly #Gardasil #Health #keytruda #Merck #Mounjaro #Roche #Sanofi #Washington
    newsbeep.com/us/571163/

  4. Global drug makers face pricing pressure as China targets affordable healthcare

    Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
    #NewsBeep #News #Healthcare #AstraZeneca #Beijing #China #DonaldTrump #EliLilly #Gardasil #Health #healthcare #Keytruda #merck #Mounjaro #Roche #SANOFI #UK #UnitedKingdom #UnitedStates #Washington
    newsbeep.com/uk/518906/

  5. @hundhamm

    #Familienunternehmer #dm #rossmann #vorwerk #kaercher #miele #bosch #bmw #lidl #deichmann #merck #müller

    Achtung:
    Es handelt sich bei der Greenpeace-Studie um die "Stiftung Familienunternehmen", die aktuelle Diskussion dreht sich aber um den "Verband der Familienunternehmer".

    ...ich nehme aber an, dass etliche Firmen in Beidem Mitglied sind...

    Edit:
    Hier noch ein Link zu einem taz-Artikel, in dem über Verband _und_ Stiftung berichtet wird:
    taz.de/Familienunternehmer-und

  6. GI Innovation is set to sign South Korea’s first immuno-oncology technology licensing deal with Merck, potentially marking a milestone for the domestic biotech sector as talks near completion for GI-101 and GI-102 combination with Keytruda.
    #YonhapInfomax #GIInnovation #Merck #ImmunoOncology #Keytruda #TechnologyTransfer #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  7. @waltman I remember when I arrived at #Merck (#MSD) in 1995, people spoke warmly of the recently-retired Roy Vagelos' time as president and CEO. There's something to be said for having a physician lead a pharmaceutical company.

  8. Merck claims late-stage study success for RSV antibody  — Novo Nordisk's Wegovy gets UK approval for lowering heart risks — J&J vets burst into biotech with $165M Third Arc series A —bit.ly/w28kSd #rsv #merck #novonordisk #uk #wegovy #funding #jnj #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  9. Merck claims late-stage study success for RSV antibody  — Novo Nordisk's Wegovy gets UK approval for lowering heart risks — J&J vets burst into biotech with $165M Third Arc series A —bit.ly/w28kSd #rsv #merck #novonordisk #uk #wegovy #funding #jnj #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  10. Merck claims late-stage study success for RSV antibody  — Novo Nordisk's Wegovy gets UK approval for lowering heart risks — J&J vets burst into biotech with $165M Third Arc series A —bit.ly/w28kSd #rsv #merck #novonordisk #uk #wegovy #funding #jnj #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  11. Merck claims late-stage study success for RSV antibody  — Novo Nordisk's Wegovy gets UK approval for lowering heart risks — J&J vets burst into biotech with $165M Third Arc series A —bit.ly/w28kSd #rsv #merck #novonordisk #uk #wegovy #funding #jnj #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  12. Supreme Court rejects controversial Purdue Pharma bankruptcy deal—FDA approves Verona Pharma's inhaled COPD therapy —FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug—bit.ly/w28kSd #supremecourt #purduepharma #bankruptcy #opioidcrisis #fda #copd #merck #cancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  13. AstraZeneca’s Truqap flops in phase III triple-negative breast cancer trial—Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval —Roche partners with RNA editing biotech Ascidian—bit.ly/w28kSd #astrazeneca #breastcancer #clinicaltrials #endometrialcancer #merck #fda #rna #roche #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  14. ASCO: AstraZeneca's Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation—Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up — Eli Lilly adds ALS drug prospect with QurAlis deal--bit.ly/w28kSd #asco2024 #oncology #cancer #astrazeneca #moderna #elililly #als #lungcancer #merck #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  15. Merck’s potential $3B EyeBio acquisition puts drugmaker back in ophthalmology—J&J's depression treatment succeeds in late-stage study — AstraZeneca throws its hat into the oral PCSK9 ring--bit.ly/w28kSd #merck #mergersandacquistions #clinicaltrials #ophthalmology #depression #jnj #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  16. Merck’s potential $3B EyeBio acquisition puts drugmaker back in ophthalmology—J&J's depression treatment succeeds in late-stage study — AstraZeneca throws its hat into the oral PCSK9 ring--bit.ly/w28kSd #merck #mergersandacquistions #clinicaltrials #ophthalmology #depression #jnj #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  17. Merck’s potential $3B EyeBio acquisition puts drugmaker back in ophthalmology—J&J's depression treatment succeeds in late-stage study — AstraZeneca throws its hat into the oral PCSK9 ring--bit.ly/w28kSd #merck #mergersandacquistions #clinicaltrials #ophthalmology #depression #jnj #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  18. Merck’s potential $3B EyeBio acquisition puts drugmaker back in ophthalmology—J&J's depression treatment succeeds in late-stage study — AstraZeneca throws its hat into the oral PCSK9 ring--bit.ly/w28kSd #merck #mergersandacquistions #clinicaltrials #ophthalmology #depression #jnj #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  19. Keytruda strikes out again in endometrial cancer with phase III flop—Novo inks $600M deal with Metaphore to develop next-gen obesity drugs —Takeda Pharma to restructure after annual profit slump --bit.ly/w28kSd #merck #keytruda #endometrialcancer #clinicaltrials #novonordisk #obesity #drugdevelopment #takeda #restructuring #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  20. On Tuesday, #Johnson & #Johnson became the latest drugmaker to take the Biden administration to federal court in an attempt to put a #halt to the #drug #pricing #program. Three other drug companies — #Merck, #Bristol #Myers #Squibb and #Astellas #Pharma — have filed their own lawsuits, as have the industry’s main trade group and the U.S. #Chamber of #Commerce.

    The suits make similar and overlapping claims that the drug pricing provisions are #unconstitutional. They are scattered in federal courts around the country — a tactic that experts say gives the industry a better chance of obtaining #conflicting #rulings that will put the legal challenges on a fast track to a business-friendly #Supreme #Court.

    nytimes.com/2023/07/23/us/poli

  21. #Biotech #MandA gets off to a 'blistering' start in 2023, as insiders predict surge in deals
    Already, #biopharma companies have tallied $64 billion in #mergers and #acquisitions deals this year. In the last few weeks alone, #Pfizer said it will pay $43 billion for #Seagen, #Merck agreed to acquire #PrometheusBiosciences for $10.8 billion, and #GSK said it will buy #BellusHealth for $2 billion. It’s a “blistering” pace on track for $300 billion by year’s end!!
    endpts.com/biotech-ma-gets-off #capitalism